These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 30839094

  • 1. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H, Jin J, Liang S, Zhao L, Gong J, He Q.
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [Abstract] [Full Text] [Related]

  • 2. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M, Zheng D, Liang X, Wu D, Hu K, Jin J, He Q.
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [Abstract] [Full Text] [Related]

  • 3. Tripterygium glycoside protects against puromycin amino nucleoside‑induced podocyte injury by upregulating autophagy.
    Gong J, Jin J, Zhao L, Li Y, Li Y, He Q.
    Int J Mol Med; 2018 Jul; 42(1):115-122. PubMed ID: 29620171
    [Abstract] [Full Text] [Related]

  • 4. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
    Wang Y, Li H, Song SP.
    Med Sci Monit; 2018 Mar 24; 24():1724-1732. PubMed ID: 29572435
    [Abstract] [Full Text] [Related]

  • 5. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ, Jiang L, Li YY, Huang YB, Hu XR, Zhu W, Wang X, Wu YG, Meng XM, Qi XM.
    Acta Pharmacol Sin; 2022 Jan 24; 43(1):96-110. PubMed ID: 34253875
    [Abstract] [Full Text] [Related]

  • 6. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX, Zhao N, Zhang W.
    Zhonghua Nei Ke Za Zhi; 2013 Jun 24; 52(6):469-73. PubMed ID: 24059992
    [Abstract] [Full Text] [Related]

  • 7. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
    Jin J, Ye M, Zhao L, Zou W, Shen W, Zhang H, Gong J, He Q.
    Histol Histopathol; 2018 Aug 24; 33(8):803-814. PubMed ID: 29446059
    [Abstract] [Full Text] [Related]

  • 8. Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K/AKT signaling pathway.
    Zhang Z, Huang H, Tao Y, Liu H, Fan Y.
    Ren Fail; 2024 Dec 24; 46(2):2410396. PubMed ID: 39378103
    [Abstract] [Full Text] [Related]

  • 9. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
    Zheng D, Tao M, Liang X, Li Y, Jin J, He Q.
    Histol Histopathol; 2020 Apr 24; 35(4):405-415. PubMed ID: 31650524
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
    Zhang X, Zhang L, Wen Y, Zhang M, Liu S, Xiao H.
    Kidney Blood Press Res; 2023 Apr 24; 48(1):314-325. PubMed ID: 37054686
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor 1 knockdown attenuates high glucose-induced podocyte injury by promoting the JAK2/STAT signalling-mediated autophagy.
    Zhang Y, Liu M, Wu Y, Xu Y, Hong Y, Xiang H.
    Nephrology (Carlton); 2024 Jul 24; 29(7):394-404. PubMed ID: 38586891
    [Abstract] [Full Text] [Related]

  • 12. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
    Jin D, Liu F, Yu M, Zhao Y, Yan G, Xue J, Sun Y, Zhao D, Li X, Qi W, Wang X.
    J Ethnopharmacol; 2022 Jul 15; 293():115246. PubMed ID: 35398500
    [Abstract] [Full Text] [Related]

  • 13. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M, Li Y, Wang L, Guo B, Mei W, Zhu B, Zhang J, Ding Y, Meng B, Zhang L, Xiang L, Dong J, Liu M, Xiang L, Xiang G.
    Diabetologia; 2020 Sep 15; 63(9):1916-1931. PubMed ID: 32588068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway.
    Liu H, Wang J, Yue G, Xu J.
    Ren Fail; 2024 Dec 15; 46(1):2303396. PubMed ID: 38234193
    [Abstract] [Full Text] [Related]

  • 16. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D, Liu Y, Chen J, Lin H, Guo H, Wu Y, Xu Y, Zhou Y, Zhou W, Lu R, Zhou J, Wu J.
    Eur J Pharmacol; 2021 Jul 05; 902():174121. PubMed ID: 33901462
    [Abstract] [Full Text] [Related]

  • 17. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J, Ye M, Hu K, Gong J, He Q.
    Histol Histopathol; 2019 Jun 05; 34(6):671-682. PubMed ID: 30475382
    [Abstract] [Full Text] [Related]

  • 18. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
    Zhaoan G, Lina S, Yingying L, Ruifeng LI, Chong L, Ke D, Jing S, Jun S.
    J Tradit Chin Med; 2023 Aug 05; 43(4):667-675. PubMed ID: 37454251
    [Abstract] [Full Text] [Related]

  • 19. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
    Wang Y, Peng L, Lu X, Zhang H, Zhao H, Zhao T, Yang L, Mao H, Ma F, Liu T, Li P, Zhan Y.
    J Ethnopharmacol; 2024 Apr 24; 324():117721. PubMed ID: 38199335
    [Abstract] [Full Text] [Related]

  • 20. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.
    Han J, Zhang Y, Shi X, Peng Z, Xing Y, Pang X.
    J Tradit Chin Med; 2021 Feb 24; 41(1):125-132. PubMed ID: 33522205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.